Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.48 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.48 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16969827 | 1.00 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL16970300 | 1.00 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL16969897 | 1.00 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL5833810 | 0.97 | — | — | |
| SCHEMBL10758807 | 0.88 | — | — | |
| SCHEMBL16969890 | 0.83 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL16969780 | 0.83 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL16970076 | 0.83 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL16969885 | 0.83 | FDPS (0.48) | FDPSGGPS1SMPD1TSHRTHRB | |
| SCHEMBL30570453 | 0.81 | FDPS (0.46) | FDPSGGPS1SMPD1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352376-B2 | Catalysts | BOREALIS AG (AT) | 2022-06-07 | — | — | US | disclosed |
| EP-3541823-B1 | CATALYSTS | BOREALIS AG (AT) | 2020-12-30 | — | — | EP | disclosed |
| US-20190308995-A1 | CATALYSTS | BOREALIS AG (AT) | 2019-10-10 | — | — | US | disclosed |
| EP-3541823-A1 | CATALYSTS | Borealis AG (AT) | 2019-09-25 | — | — | EP | disclosed |
| EP-2722345-B1 | CATALYST FOR THE POLYMERISATION OF OLEFINS | BOREALIS AG (AT) | 2018-12-05 | — | — | EP | disclosed |
| CN-108409895-A | Catalyst | 博瑞立斯有限公司 | 2018-08-17 | — | — | CN | disclosed |
| WO-2018091684-A1 | CATALYSTS | BOREALIS AG (AT) | 2018-05-24 | — | — | WO | disclosed |
| EP-2729479-B1 | CATALYSTS | BOREALIS AG (AT) | 2017-09-06 | — | — | EP | disclosed |
| EP-2905349-B1 | Ag ball, solder joint, formed solder, solder paste and silver paste | SENJU METAL INDUSTRY CO (JP) | 2017-05-17 | — | — | EP | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-4129732-A | BACTERICIDE | PFIZER INC. (US) | 1978-12-12 | — | — | US | disclosed |
| US-4121040-A | CEPHALOSPORIN ANTIBIOTICS | PFIZER INC. (US) | 1978-10-17 | — | — | US | disclosed |
| US-4113942-A | ANTIBACTERIAL | PFIZER INC. (US) | 1978-09-12 | — | — | US | disclosed |
| US-4109085-A | ANTIBIOTICS, BACTERICIDES | PFIZER INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4109083-A | CEPHALOSPORIN ANTIBIOTICS | PFIZER INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4045437-A | ANTIBACTERIAL | PFIZER, INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-4045436-A | ANTIBACTERIAL | PFIZER INC. (US) | 1977-08-30 | — | — | US | disclosed |
| US-4039533-A | CEPHALOSPORINS | PFIZER INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-4039532-A | BACTERICIDES | PFIZER INC. (US) | 1977-08-02 | — | — | US | disclosed |
| US-3966719-A | ANTIBACTERIAL | PFIZER INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352376-B2 | Catalysts | SIGMAR1, H1-2, SFN | FDPS 4815/4885GGPS1 4514/4885SMPD1 4424/4885 |
| US-20190308995-A1 | CATALYSTS | SIGMAR1, H1-2, CBR1 | FDPS 4808/4885GGPS1 4516/4885SMPD1 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.